Alexandre A S Soares1, Thauany M Tavoni2, Eliane C de Faria3, Alan T Remalay4, Raul C Maranhão2, Andrei C Sposito5. 1. Cardiology Division, State University of Campinas, Campinas, São Paulo, Brazil; Laboratory of Atherosclerosis and Vascular Biology, State University of Campinas, Campinas, São Paulo, Brazil. 2. Laboratory of Metabolism and Lipids, Heart Institute, University of São Paulo, São Paulo, São Paulo, Brazil; Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, São Paulo, Brazil. 3. Department of Clinical Pathology, State University of Campinas, Campinas, São Paulo, Brazil. 4. National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, United States. 5. Cardiology Division, State University of Campinas, Campinas, São Paulo, Brazil; Laboratory of Atherosclerosis and Vascular Biology, State University of Campinas, Campinas, São Paulo, Brazil. Electronic address: sposito@fcm.unicamp.br.
Abstract
BACKGROUND: The transport of lipids from the artery wall is one of the most essential anti-atherogenic functions of high-density lipoprotein (HDL). Recent reports of changes in the HDL composition, during myocardial infarction (MI), suggest that this function may be altered. METHODS: Forty-one consecutive patients with ST-segment elevation MI enrolled at the Brasilia Heart Study were selected. The following HDL-related measures were determined upon admission (D1) and on the fifth day (D5) after MI: C-reactive protein, CETP and PLTP activity, HDL composition, efflux of cholesterol from J774 macrophages to HDL, and transfer of unesterified and esterified cholesterol, triglycerides and phospholipids from a donor nanoemulsion to HDL. RESULTS: From D1 to D5, the activity of CETP decreased by 25%, but PLTP activity remained unchanged. Esterified cholesterol (-23%) and phospholipid (-9.5%) contents of HDL decreased. Transfer of triglycerides (-36.5%) and esterified cholesterol (-14.7%) to HDL from nanoemulsions was reduced, but other lipids transfers were unchanged. Cholesterol efflux to HDL was also diminished by 8.5% (p=0.04) on D5 compared to D1. It was more pronounced in patients above the 75th percentile of C-reactive protein. CONCLUSIONS: After an MI, a simultaneous decrease in lipid transfer to HDL and in the capacity of HDL to efflux cholesterol from cells occurs. Thus, HDL with inferior atheroprotective properties may be generated in the acute post-MI period.
BACKGROUND: The transport of lipids from the artery wall is one of the most essential anti-atherogenic functions of high-density lipoprotein (HDL). Recent reports of changes in the HDL composition, during myocardial infarction (MI), suggest that this function may be altered. METHODS: Forty-one consecutive patients with ST-segment elevation MI enrolled at the Brasilia Heart Study were selected. The following HDL-related measures were determined upon admission (D1) and on the fifth day (D5) after MI: C-reactive protein, CETP and PLTP activity, HDL composition, efflux of cholesterol from J774 macrophages to HDL, and transfer of unesterified and esterified cholesterol, triglycerides and phospholipids from a donor nanoemulsion to HDL. RESULTS: From D1 to D5, the activity of CETP decreased by 25%, but PLTP activity remained unchanged. Esterified cholesterol (-23%) and phospholipid (-9.5%) contents of HDL decreased. Transfer of triglycerides (-36.5%) and esterified cholesterol (-14.7%) to HDL from nanoemulsions was reduced, but other lipids transfers were unchanged. Cholesterol efflux to HDL was also diminished by 8.5% (p=0.04) on D5 compared to D1. It was more pronounced in patients above the 75th percentile of C-reactive protein. CONCLUSIONS: After an MI, a simultaneous decrease in lipid transfer to HDL and in the capacity of HDL to efflux cholesterol from cells occurs. Thus, HDL with inferior atheroprotective properties may be generated in the acute post-MI period.
Authors: Bronwyn A Kingwell; Stephen J Nicholls; Elena Velkoska; Svetlana A Didichenko; Danielle Duffy; Serge Korjian; C Michael Gibson Journal: J Am Heart Assoc Date: 2022-04-12 Impact factor: 6.106
Authors: Cicero P Albuquerque; Fatima R Freitas; Ana Elisa M Martinelli; Josefa H Lima; Rafael F Coelho; Carlos V Serrano; Willian C Nahas; Roberto Kalil Filho; Raul C Maranhão Journal: Lipids Health Dis Date: 2020-06-10 Impact factor: 3.876
Authors: Bo Zheng; Danielle Duffy; Pierluigi Tricoci; Helen Kastrissios; Marc Pfister; Samuel D Wright; Andreas Gille; Michael A Tortorici Journal: Br J Clin Pharmacol Date: 2020-12-23 Impact factor: 4.335